About 379 results
Open links in new tab
  1. Closed System Drug-Transfer Device (CSTD) Research

    Feb 9, 2024 · Overview NIOSH defines a Closed System Drug-Transfer Device (CSTD) as "a drug transfer device that mechanically prohibits the transfer of environmental contaminants …

  2. NIOSH researchers to develop a performance test protocol for closed system transfer devices (CSTDs) [NIOSH 2004]. A CSTD, also known as a closed system drug-transfer device, is used …

  3. Docket 288-A: Test Protocol for Closed System Transfer Devices

    Jun 1, 2017 · NIOSH held a public meeting to discuss a universal closed system drug-transfer device (CSTD) testing (draft) protocol entitled, A Performance Test Protocol for Closed …

  4. Peer Review Plan for Hazardous Drug Containment Protocol

    Jan 2, 2025 · NIOSH created a peer review plan for a vapor containment performance protocol for Closed System Drug-Transfer Devices (CSTDs). These devices help protect healthcare …

  5. A Vapor Containment Performance Protocol for Closed System …

    NIOSH the availability of the following draft document for public comment entitled A Vapor Containment Performance Protocol for Closed System Transfer Devices Used During …

  6. Hazardous Drugs Resources | Healthcare Workers | CDC

    Impact and appreciation of two methods aiming at reducing hazardous drug environmental contamination: The centralization of the priming of IV tubing in the pharmacy and use of a …

  7. Centers for Disease Control and Prevention | CDC

    Centers for Disease Control and Prevention | CDC

  8. In addition to double gloving and a protective gown, an engineering control such as a BSC or CACI, possibly sup-plemented with a CSTD (closed system drug-transfer device), is …

  9. Closed system drug-transfer device (CSTD): A drug-transfer device that mechanically prohibits the transfer of environmental contaminants into the system and the escape of hazardous drug …

  10. Antineoplastic Agents Risk Factors | Healthcare Workers | CDC

    Apr 19, 2024 · Determination of extended sterility for single-use vials using the Phaseal closed-system transfer device. J Hematol Oncol Pharm. 2016; 6:46-50. Hon CY, Teschke K and Shen …